Ishita Drugs Board approves ₹11.75 Cr borrowing from HDFC Bank

The Board of Directors of Ishita Drugs and Industries Limited, in a meeting held on September 22, 2026, approved borrowings totaling ₹11.75 Crore from HDFC Bank Limited. This includes a Term Loan of ₹9.75 Crore and a Working Capital Facility of ₹2.00 Crore. The borrowing is in accordance with the terms and conditions outlined in HDFC Bank's Sanction Letter dated September 17, 2026. The company confirmed that these borrowings are within the limits approved by its shareholders at the 31st Annual General Meeting held on September 30, 2024, as per Section 180(1)(c) of the Companies Act, 2013.